Article Details

ProfoundBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of PRO1107 ... - PR Newswire

Retrieved on: 2024-02-05 21:00:45

Tags for this article:

Click the tags to see associated articles and topics

ProfoundBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of PRO1107 ... - PR Newswire. View article details on hiswai:

Excerpt

Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up